Recent Company News

• 09:52 PM ET May 04, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 07:24 PM ET May 05, 2025
  

  Street Takeaways - Immutep efti + Keytruda result update (A$0.31, 0.00)

• 04:32 PM ET May 05, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 06:31 PM ET May 04, 2025
  

  Immutep reports median Overall Survival of 17.6 months achieved in Cohort B of TACTI-003 Phase IIb trial (A$0.27, 0.00)

• 07:08 PM ET Apr 28, 2025
  

  Immutep reports Q3 net cash from / (used in) operating activities (A$16.3M) - Appendix 4C (A$0.26, 0.00)

• 12:53 AM ET Apr 16, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (34 total)

• 10:18 AM ET Apr 07, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (1167 total)

• 12:55 AM ET Apr 07, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (196 total)